A randomized controlled trial for low-dose continuous Infusion of human atrial natriuretic peptide for cardiac dysfunction undergoing cardiac surgery
Phase 3
- Conditions
- myocardial infarction, angina
- Registration Number
- JPRN-UMIN000001652
- Lead Sponsor
- ihon University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
cardiogenic shock renal dysfunction with hemodyalysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early postoperative outcome(mortality and complications) Long-term results(cardiac death-and events-free rate, overall survival rate after surgery))
- Secondary Outcome Measures
Name Time Method cardiac function(UCG, BNP) renal function (sCr,eGFR,Maximum sCr,Increase of Cr,(pre-max. sCr) > 0.3 mg/dl) ANP, renin, anigotensin-II, aldsterone